about
Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection.Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID)NK cells and CD1d-restricted NKT cells respond in different ways with divergent kinetics to IL-2 treatment in primary HIV-1 infectionExpansion of CD1d-restricted NKT cells in patients with primary HIV-1 infection treated with interleukin-2B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profileInvariant natural killer T (iNKT) cell exhaustion in sarcoidosis.Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4.When diet and exercise are not enough, think immunomodulation.Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological disease.Automated analysis of two- and three-color fluorescent Elispot (Fluorospot) assays for cytokine secretionInhibition of Ubc13-mediated Ubiquitination by GPS2 Regulates Multiple Stages of B Cell Development.HIV-specific cytotoxic cell frequencies measured directly ex vivo by the Lysispot assay can be higher or lower than the frequencies of IFN-gamma-secreting cells: anti-HIV cytotoxicity is not generally impaired relative to other chronic virus responsThe balance between influenza- and RSV-specific CD4 T cells secreting IL-10 or IFNgamma in young and healthy-elderly subjects.Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients.
P50
Q33773625-AF336095-4EC6-4EFA-8AE0-017EF13263B3Q34115373-00B1C025-F59B-43DC-9524-0840F96F4946Q34680046-1A7C2CA7-EE21-4AEC-AE66-4454B03628E7Q35849560-B6DA6A3D-EEDD-4572-A7E1-C0CABD6CECB4Q36729660-A74B8005-DE64-428D-BC3A-C2404F5EF8CBQ37406517-B4824CD4-3A94-4D47-9611-A3EBE34E8FACQ37450550-B9481F47-67DA-4879-9318-F8AEB1862192Q38053226-F5C6262D-AD4C-42B9-919D-57A125E975BEQ39297216-76C9950B-B67C-497A-8AF4-113798F3556DQ40936217-CC8E7BC9-8BFB-48B7-A517-D9FBAB3E1CB8Q43892008-CE9AADE8-C0A7-40C8-B65A-C51B114AAABCQ45420153-7A5FECD3-BD09-42F3-A57F-16B9041E91F8Q47746707-8AECBA1E-A531-4496-9F66-40EFDD0A7510Q50971620-F4530380-1DE0-4EF2-9421-B7198F3BD44D
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jennifer E Snyder-Cappione
@en
Jennifer E Snyder-Cappione
@nl
type
label
Jennifer E Snyder-Cappione
@en
Jennifer E Snyder-Cappione
@nl
prefLabel
Jennifer E Snyder-Cappione
@en
Jennifer E Snyder-Cappione
@nl
P31
P496
0000-0002-0941-5582